{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:18:38Z","timestamp":1792721918946,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.rmed.2026.108858","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:03:55Z","timestamp":1777359835000},"page":"108858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recombinant human interleukin-7 for patients with infection-associated lymphopenia: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"257","author":[{"given":"Xin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-7536","authenticated-orcid":false,"given":"Zhibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/s12879-023-08845-1","article-title":"Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis","volume":"23","author":"El\u00e7io\u011flu","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2026.108858_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/SHK.0000000000002284","article-title":"Early persistent lymphopenia and risk of death in critically ill patients with and without sepsis","volume":"61","author":"Adigbli","year":"2024","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.rmed.2026.108858_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SHK.0000000000000981","article-title":"Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis","volume":"49","author":"Stortz","year":"2018","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.rmed.2026.108858_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/imcb.12611","article-title":"Lymphopenia in sepsis\u2014an acquired immunodeficiency?","volume":"101","author":"Finfer","year":"2023","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.rmed.2026.108858_bib5","series-title":"Open Forum Infectious Diseases","article-title":"Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis","year":"2021"},{"issue":"8","key":"10.1016\/j.rmed.2026.108858_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256205","article-title":"Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality","volume":"16","author":"Andreu-Ballester","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.rmed.2026.108858_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/08850666241226877","article-title":"Characteristics and clinical prognosis of septic patients with persistent Lymphopenia","volume":"39","author":"Jing","year":"2024","journal-title":"J. Intensive Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108858_bib8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/CCM.0000000000005993","article-title":"Early, persistent lymphopenia is associated with prolonged multiple organ failure and mortality in septic children","volume":"51","author":"Podd","year":"2023","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-020-0159-1","article-title":"Correction: lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13054-024-05099-4","article-title":"Lymphopenia in sepsis: a narrative review","volume":"28","author":"Wang","year":"2024","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib11","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc13176","article-title":"Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis","volume":"18","author":"Chang","year":"2014","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib12","article-title":"Beta\u2010blocker therapy preserves normal splenic t\u2010lymphocyte numbers reduced in proportion to sepsis severity in a sepsis model","volume":"2019","author":"Suzuki","year":"2019","journal-title":"Critical Care Res. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamainternmed.2020.5503","article-title":"Effect of recombinant human granulocyte colony\u2013stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: a randomized clinical trial","volume":"181","author":"Cheng","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12879-024-09286-0","article-title":"Effect of degalactosylated bovine glycoprotein formulations MAF and M \u0441apsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial","volume":"24","author":"Inui","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.rmed.2026.108858_bib15","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.4049\/jimmunol.1202062","article-title":"IL-7 restores lymphocyte functions in septic patients","volume":"189","author":"Venet","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2026.108858_bib16","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0903151","article-title":"IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis","volume":"184","author":"Unsinger","year":"2010","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.rmed.2026.108858_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2010.09.002","article-title":"IL-7 and lymphopenia","volume":"412","author":"Ponchel","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.rmed.2026.108858_bib18","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.1202573","article-title":"IL-7 produced by thymic epithelial cells plays a major role in the development of thymocytes and TCR\u03b3\u03b4+ intraepithelial lymphocytes","volume":"190","author":"Shitara","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2026.108858_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/annonc\/mdv173","article-title":"ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients","volume":"26","author":"Tr\u00e9dan","year":"2015","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.rmed.2026.108858_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0000000000001760","article-title":"IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy","volume":"32","author":"Sortino","year":"2018","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.rmed.2026.108858_bib21","article-title":"Immune adjuvant therapy with Interleukin-7 in a lymphopenic patient with aplastic anemia and mucormycosis","volume":"5","author":"Crees","year":"2023","journal-title":"Critical Care Explor."},{"issue":"5","key":"10.1016\/j.rmed.2026.108858_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.1700127","article-title":"IL-7 restores T lymphocyte immunometabolic failure in septic shock patients through mTOR activation","volume":"199","author":"Venet","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-022-00982-1","article-title":"Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients","volume":"12","author":"Bidar","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.rmed.2026.108858_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156049","article-title":"IL-7: comprehensive review","volume":"160","author":"Winer","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.rmed.2026.108858_bib25","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","article-title":"Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial","volume":"13","author":"Daix","year":"2023","journal-title":"Ann. Intensive Care"},{"issue":"5","key":"10.1016\/j.rmed.2026.108858_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.rmed.2026.108858_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.189150","article-title":"A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19","volume":"10","author":"Shankar-Hari","year":"2025","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.rmed.2026.108858_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16485","article-title":"Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19)","volume":"3","author":"Laterre","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.rmed.2026.108858_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20561","article-title":"The burden of hospital acquired infections and antimicrobial resistance","volume":"9","author":"Abban","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s15010-024-02355-1","article-title":"Risk factors for prolonged infection and secondary infection in pediatric severe sepsis","volume":"53","author":"Aldewereld","year":"2025","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.rmed.2026.108858_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12519-023-00689-8","article-title":"Sepsis heterogeneity","volume":"19","author":"Wang","year":"2023","journal-title":"World J. Pediatr."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib33","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1038\/s41598-024-55950-5","article-title":"The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes","volume":"14","author":"Ali","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-024-05186-6","article-title":"Lymphocyte count trajectories are associated with the prognosis of sepsis patients","volume":"28","author":"Yang","year":"2024","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.rmed.2026.108858_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12879-024-10428-7","article-title":"Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19","volume":"25","author":"Paules","year":"2025","journal-title":"BMC Infect. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:04:15Z","timestamp":1784934255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112600226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S095461112600226X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108858","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human interleukin-7 for patients with infection-associated lymphopenia: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108858"}}